Our Faculties Dr. J. Selvaraj and Prof. V. Vishnu Priya has published a patent on “Revolutionizing Cancer Therapeutics: Tapping into S. Naozhouense commercial potential agaist triple negative breast cancer by modulating the P13K/AKT.BCL-2 signaling pathway“